STERIS plc Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
STERIS plc (STE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.02% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-07
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 4.02%, a 0.25% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 4.03%, a 4.05% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-06-30 was 4.20%, a 17.65% increase year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-06-30 was 3.57%, a 48.13% increase year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2026 was 4.02%, a 4.51% decline from fiscal 2025.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.21%, a 17.27% increase from fiscal 2024.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.59%, a 47.13% increase from fiscal 2023.
- STERIS plc share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 2.44%, a 121.82% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.02% 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | 4.02% 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | 4.03% 10-Q · filed 2026-02-06 | ||||
| 2025-09-30 | 4.03% 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 4.03% 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | 4.21% 10-K · filed 2026-05-29 | ||||
| 2024-12-31 | 4.21% 10-Q · filed 2026-02-06 | ||||
| 2024-09-30 | 4.20% 10-Q · filed 2025-11-06 | 4.21% 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 4.20% 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 3.59% 10-K · filed 2026-05-29 | ||||
| 2023-12-31 | 3.59% 10-Q · filed 2025-02-07 | ||||
| 2023-09-30 | 3.59% 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | 3.57% 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | 2.44% 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | 2.44% 10-Q · filed 2024-02-08 | ||||
| 2022-09-30 | 2.44% 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | 2.41% 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | 1.10% 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | 1.10% 10-Q · filed 2023-02-08 | ||||
| 2021-09-30 | 1.16% 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 1.16% 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | 0.46% 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | 0.46% 10-Q · filed 2022-02-09 | ||||
| 2020-09-30 | 0.46% 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | 0.46% 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | 2.26% 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | 2.26% 10-Q · filed 2021-02-09 | ||||
| 2019-09-30 | 2.26% 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | 2.27% 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | 2.64% 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | 2.64% 10-Q · filed 2020-02-10 | ||||
| 2018-09-30 | 2.63% 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 2.62% 10-Q · filed 2019-08-07 | ||||
| 2018-03-31 | 2.01% 8-K · filed 2021-02-09 | ||||
| 2017-03-31 | 1.29% 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |